standard-title
Alzheimer’s Disease
Latest News Regarding Alzheimer’s Disease and Your Health
Loading…
New research suggests that vital exhaustion, a marker of psychological distress, may raise the risk of developing Alzheimer’s disease. Psychological distress in midlife may bring about dementia later on, suggests new research. Many factors may increase Alzheimer’s risk, including age, family history, and genetic makeup. Certain health issues, such as cardiovascular disease or diabetes, may also influence the odds of experiencing dementia because they impact the blood vessels. New research indicates that psychological factors could also affect risk. Psychological distress, in particular, may increase the likelihood of developing dementia, suggests the new study. Specifically, researchers led by Sabrina Islamoska, a doctoral candidate in the Department of Public Health at the University of Copenhagen, Denmark, set out to investigate the possibility of a link between vital exhaustion and Alzheimer’s disease. Vital exhaustion describes “a mental state of psychological distress” that manifests as irritability, fatigue, and a feeling of demoralization. As the researchers explain, vital exhaustion may be a reaction to “unsolvable problems” in one’s life, especially when the person has been exposed to stressors for a prolonged period. So, vital exhaustion can be seen as a sign of psychological distress. Previous studies have noted that vital exhaustion may raise the risk […]
A recent study suggests that a warning sign may come before any symptoms of Alzheimer’s disease: Adults who do not get enough deep sleep may be on their way to developing the disease. A lack of deep sleep may lead to Alzheimer’s disease. Researchers from the Washington University School of Medicine in St. Louis, MO, found that older people who experience less slow-wave sleep (in other words, deep sleep) have elevated levels of a brain protein called tau. The findings, published in Translational Medicine, note that higher levels of tau are a sign of Alzheimer’s disease. Elevated levels have also previously been associated with both brain damage and cognitive decline. Slow-wave sleep and brain proteins Slow-wave sleep helps people consolidate their memories and experiences, and getting enough of this type of sleep helps people wake up refreshed and energized. In order to find out if there is a connection between a lack of deep sleep and the development of Alzheimer’s, the authors put together a study that involved 119 people aged 60 years or older. A full 80 percent of the participants had no cognition problems, and the rest had only mild impairment. To conduct the study, researchers monitored their […]
New research in the Journal of Biological Chemistry breaks down the process through which tau tangles grow as long as they do. The findings may lead to new therapies that target the formation of tau aggregates in Alzheimer’s disease. Researchers knew that Alzheimer’s-related tau aggregates consisted of a small number of long tau fibrils. One of the hallmarks of Alzheimer’s disease is the so-called tau tangles. Tau is a protein contained within the axons of the nerve cells. More specifically, tau helps form microtubules — essential structures that transport nutrients within nerve cells. In a healthy brain, the tau protein helps these microtubules remain straight and strong. But in Alzheimer’s, tau collapses into aggregates called tangles. When this happens, the microtubules can no longer sustain the transport of nutrients and other essential substances in the nerve cells, which eventually leads to cell death. How toxic and damaging these tau tangles can be, and how far they can spread, depends on their length. However, until now, scientists did not know why some tau tangles are longer than others in Alzheimer’s, or how these aggregates grow so long in the first place. But now, scientists at the Ohio State University in Columbus […]
Regular exposure to stress can impact our physical and mental health, but how does it actually affect our brains? One new Harvard Medical School study answers that question. According to new research, high levels of stress hormones can impact how well the brain functions. Stress — especially when we experience it on a regular basis — takes a significant toll on our minds and bodies. It can make us feel more irritable and constantly tired, and it impacts our ability to focus. Chronic stress can also interfere with our sleep patterns, appetite, and libido, and it can also exacerbate a range of health conditions. These include diabetes, heart disease, and gastrointestinal problems. One study that Medical News Today covered earlier this year, in fact, saw that even minor levels of distress can increase a person’s risk of chronic disease. What impact does stress have on the brain in physiological and cognitive terms? Researchers from Harvard Medical School in Boston, MA, have explored this question and reported their answer in the journal Neurology. The stress hormone affects memory In their study, the researchers worked with participants with an average age of 49 and no diagnosis of dementia. At baseline, the investigators […]
Millions of people worldwide live with a form of dementia, the most common of which is Alzheimer’s disease. Currently, there is no way to halt its progress, but clinical trials of new drugs are underway. What approach will serve specialists best? A new review of clinical trials advises on the best way forward. According to the World Health Organization (WHO), approximately 50 million people around the world live with dementia, and approximately 60–70 percent have Alzheimer’s disease. The greatest risk factor for Alzheimer’s disease is aging, and people ages 65 or older are the most vulnerable. Current treatments for this condition address its symptoms, such as memory loss and behavioral changes. However, more and more research aims to find a therapy that will tackle the biological changes that characterize Alzheimer’s disease. But are researchers on the right track with their investigations, and what would be the best treatment approach? A new comprehensive review published in the journal Neurology, and available online, addresses these questions. Most trials target brain pathologies In the review, specialists from the Alzheimer’s Drug Discovery Foundation in New York, NY analyze current clinical trials for dementia drugs and advise about the best approach going forward. “Alzheimer’s is […]
Latest Alzheimer’s News TUESDAY, Jan. 22, 2019 (HealthDay News) — Leaky blood vessels in the brain may be an early sign of Alzheimer’s disease, researchers say. They followed 161 older adults for five years and found that those with the most severe memory declines had the greatest leakage in their brain’s blood vessels, regardless of whether the Alzheimer’s-related proteins amyloid and tau were present. The findings could help with earlier diagnosis of Alzheimer’s and suggest a new drug target for slowing down or preventing the disease, according to the researchers from the University of Southern California. “The fact that we’re seeing the blood vessels leaking, independent of tau and independent of amyloid, when people have cognitive [mental] impairment on a mild level, suggests it could be a totally separate process or a very early process,” said study senior author Dr. Berislav Zlokovic. He is director of the Zilkha Neurogenetic Institute at the university’s Keck School of Medicine in Los Angeles. “That was surprising, that this blood-brain barrier breakdown is occurring independently,” Zlokovic added in a university news release. The blood-brain barrier prevents harmful substances from reaching brain tissue. In some people, this barrier weakens with age. “If the blood-brain barrier […]
Recent research into older adults confirms that loneliness is tied to a raised risk of developing dementia. The study also reveals that the effect ranges across a diversity of people and is independent of how much social contact they have. A large new study confirms that loneliness is a risk factor for dementia. Scientists from Florida State University (FSU) in Tallahassee used data on 12,030 individuals from the Health and Retirement Study, a United States government-sponsored longitudinal survey of a nationally representative sample of people aged 50 and older. They report their findings in a paper that now features in The Journals of Gerontology: Series B. “We are not the first people,” says first study author Dr. Angelina Sutin, who is an associate professor in FSU’s College of Medicine, “to show that loneliness is associated with increased risk of dementia.” “But this is by far the largest sample yet, with a long follow-up,” she adds. “And the population was more diverse.” The study data contained measures of loneliness and social isolation and a range of risk factors, including behavioral, clinical, and genetic. Through telephone interviews, individuals had also completed assessments of cognitive ability, a low score on which indicates dementia. […]
(HealthDay News) — If you are caring for a loved one who has Alzheimer’s disease, you may develop feelings of grief as the person starts to change, the Alzheimer’s Foundation says. Latest Alzheimer’s News There are five phases of grieving: denial, anger, guilt, sadness and acceptance. The association suggests how to cope with grief and loss: Face your feelings and accept them. Prepare to have feelings of loss as dementia progresses. Understand that no two people grieve in exactly the same way. Talk with someone you trust about your feelings. Stay involved in activities that you enjoy. Join a support group. Accept things that you cannot change. Take care of yourself. Copyright © 2018 HealthDay. All rights reserved. CONTINUE SCROLLING FOR NEXT NEWS ARTICLE
Parkinson’s disease is a neurological condition with a wide range of effects, including problems with movement, blood pressure and thinking, and mood, sensory, and sleep difficulties. The symptoms of Parkinson’s disease (PD) usually begin gradually, and they affect each person differently. The symptoms a person has will vary widely, regardless of how severe they are or how quickly they develop. Read on to find out more about the different types of symptoms and how to recognize the early symptoms of PD. Early symptoms Around 7 out of 10 people with PD experience tremor at some stage. The symptoms of PD affect individuals differently, but some can be an early sign of the disease. These are: REM sleep disorder and other sleep problems the loss of the sense of smell tremor, especially in one hand a smaller size of handwriting difficulty moving or walking or a stooping gait constipation loss of facial expression, that may make the person look emotionless a low or soft voice Primary motor symptoms The four main signs and symptoms include: slow physical movements, known as bradykinesia shaking, or tremor muscle stiffness, or rigidity problems with balance and coordination, known as postural instability Symptoms often start on […]
Scientists have now proved that drinking certain types of coffee can be beneficial to brain health, but how does this popular brew support cognitive function? A new study identifies some of the mechanisms that allow coffee to keep mental decline at bay. What makes coffee an ally of brain health? According to data from the Harvard T.H. Chan School of Public Health in Boston, MA, about 54 percent of all adults in the United States drink coffee on a daily basis. While drinking coffee can bring both benefits and risks for a person’s health, a 2016 study from the University of Ulster in Coleraine, United Kingdom, concluded that the health benefits of moderate coffee consumption “clearly outweigh” the potential risks. One of these benefits is that coffee seems to protect the brain against cognitive impairments and boost thinking skills. How does this happen, and what is it about coffee that is so beneficial to cognitive health? These are some questions that a new study from the Krembil Brain Institute — part of the Krembil Research Institute in Toronto, Canada — aims to answer. “Coffee consumption does seem to have some correlation to a decreased risk of developing Alzheimer’s disease and […]
Scientists have uncovered a mechanism through which a toxic brain protein that is a hallmark of Alzheimer’s disease can damage neurons, or brain cells. New research uncovers the mechanism that leads to the progressive loss of brain cells that characterizes Alzheimer’s disease. The team at the Grenoble Institute of Neurosciences in France that made the discovery also suggests a potential way to disarm the mechanism during the early stages of the disease. The study concerns the functioning of dendritic spines, which are the tiny structures in the branching parts of brain cells that receive signals from other brain cells. It appears that beta-amyloid, a toxic protein that builds up in the brains of people with Alzheimer’s disease, triggers a mechanism that disrupts the functioning of dendritic spines. The mechanism disables a protein called cofilin 1, and the activity of this protein is crucial for the healthy functioning of dendritic spines. The Journal of Neuroscience has recently published a study paper on the research. It describes how the team used brain tissue samples from mouse models and people with Alzheimer’s disease to arrive at their findings. A key finding was that exposure to beta-amyloid peptides, which are the building blocks of […]
Recent research reveals that leaky capillaries in the brain could have a role in the development of Alzheimer’s disease. Changes in blood vessel permeability offer new clues about the onset of dementia. Dementia, the main type of which is Alzheimer’s disease, affects about 50 million people worldwide. According to the Alzheimer’s Association, over 5 million people in the United States are living with Alzheimer’s. This number is expected to reach 14 million by 2050. For this reason, it is becoming more and more important to diagnose these health conditions earlier, and to locate new targets for drugs to slow down or prevent the condition. The Food and Drug Administration (FDA) have approved some drugs that help with the symptoms of Alzheimer’s disease, but none of them treat the underlying cause. A new study conducted at the University of Southern California (USC) in Los Angeles could pave the way for new, more effective treatments. The findings now appear in the journal Nature Medicine. Leaky capillaries in the brain Previous studies indicated that two toxic proteins, amyloid and tau, may be “the trigger and bullet” in the development of Alzheimer’s. Findings showed that soluble forms of amyloid and tau work together to […]
New research finds that a 6-month regimen of aerobic exercise can reverse symptoms of mild cognitive impairment in older adults. Just 6 months of exercise that raises the heart rate can reverse signs of age-related cognitive impairment. Mild cognitive impairment (MCI) is characterized by a mild loss of cognitive abilities, such as memory and reasoning skills. A person with MCI may find it hard to remember things, make decisions, or focus on tasks. While the loss of cognitive abilities is not serious enough to interfere with daily activities, MCI raises the risk of Alzheimer’s disease and other forms of dementia. According to the Alzheimer’s Association, 15–20 percent of adults aged 65 and over in the United States have MCI. New research suggests that there might be a way to reverse these age-related cognitive problems. James A. Blumenthal, Ph.D. — of Duke University Medical Center in Durham, NC — and colleagues examined the effects of regimented exercise in 160 people aged 65 on average. They published their findings in the journal Neurology. Studying exercise, diet, and MCI The participants included in the research were sedentary at the beginning of the study. They had cardiovascular risk factors and reported symptoms of MCI. […]
By Serena GordonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Feb. 6, 2019 (HealthDay News) — There are plenty of good reasons to seek a higher education, but avoiding Alzheimer’s disease probably isn’t one of them, new research suggests. The study found that a person’s level of education wasn’t related to the onset of memory and thinking (“cognitive”) troubles, or the rate at which dementia progressed. “Education is related to cognitive growth in early life, but it wasn’t associated with cognitive change as you age. What’s more important is what you’re doing now, than what you did 40 or 50 years ago,” explained study author Robert Wilson. He’s a neuropsychologist at Rush University Medical Center in Chicago. Wilson said that continuing to do things such as learning a new language, social activities, having a purpose in life, or engaging in mentally demanding work may help keep your brain sharper as you get older. Previous research has hinted that there might be a link between education and a person’s risk of developing dementia or Alzheimer’s disease, or how fast the disease advances. But the results of a number of studies looking at this possible link have had mixed results. To try to get […]
The herpes virus could account for at least half of Alzheimer’s cases, according to a new review of the findings of three recent studies examining links between Alzheimer’s and herpes. Infection with the herpes simplex virus may boost the likelihood of developing Alzheimer’s, researchers suggest. The new paper, published in the Frontiers in Ageing Neuroscience journal, also suggests that antiviral drugs may reduce the risk of senile dementia — which is mostly caused by Alzheimer’s disease — among people who have severe cases of herpes. Herpes simplex virus 1 (HSV1) is the type of herpes that results in cold sores. HSV1 is a common virus, and the majority of people will have contracted it by the time they reach old age. However, the virus remains permanently in the body and cannot be decisively removed either by the body’s natural defense mechanisms or by drugs. The virus is inactive most of the time, but when a person has HSV1, they may find that flare-ups occur when they are stressed or sick, resulting in characteristic blisters. Medical News Today have reported on several studies this year alone that have provided evidence of a connection between Alzheimer’s and herpes. In June, we looked […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News THURSDAY, Dec. 13, 2018 (HealthDay News) — A brain protein linked to Alzheimer’s disease might potentially be transmitted to people during neurological procedures, a new preliminary study suggests. Genetically engineered lab mice developed amyloid-beta deposits in their brains after they were injected with amyloid-laced samples of human growth hormone taken from decades-old human cadavers, researchers found. “We have now provided experimental evidence to support our hypothesis that amyloid-beta pathology can be transmitted to people from contaminated materials,” said senior researcher Dr. John Collinge. He is head of University College London’s department of neurodegenerative disease. Clumps of amyloid-beta in the brain are a hallmark of Alzheimer’s disease, although researchers still don’t understand the relationship between these clumps and the degenerative brain disease. Collinge pointedly noted that this study does not mean that you can catch Alzheimer’s from another person. And animal findings often don’t replicate in humans. “Although we’re generating evidence that Alzheimer’s pathology may be transmissible, there’s absolutely no suggestion that Alzheimer’s disease itself is a contagious disease,” he said. Rebecca Edelmayer, director of scientific engagement at the Alzheimer’s Association, went even further, noting that the new study did not look at Alzheimer’s […]
Latest Alzheimer’s News FRIDAY, Jan. 18, 2019 (HealthDay News) — Frailty is associated with a higher risk of both Alzheimer’s disease and its crippling symptoms, a new study shows. “By reducing an individual’s physiological reserve, frailty could trigger the clinical expression of dementia when it might remain asymptomatic in someone who is not frail,” said study leader Dr. Kenneth Rockwood, a professor at Dalhousie University in Halifax, Canada. “This indicates that a ‘frail brain’ might be more susceptible to neurological problems like dementia as it is less able to cope with the pathological burden,” he added. The study included 456 adults in Illinois, aged 59 and older, who did not have Alzheimer’s when first enrolled in the Rush Memory and Aging Project. They underwent annual assessments of their mental and physical health, and their brains were examined after they died. By their last assessment, 53 percent of the participants had been diagnosed with possible or probable Alzheimer’s disease. For the physical assessments, the researchers created a frailty index using 41 components, including fatigue, joint and heart problems, osteoporosis, mobility and meal preparation abilities. Overall, 8 percent of the participants had significant Alzheimer’s disease-related brain changes without having been diagnosed with […]
Recent research adds to a growing body of knowledge that links hearing loss with cognitive decline, which is a hallmark of dementia and often precedes the disease. Research suggests a link between hearing loss and cognitive decline. After analyzing 8 years of data from a health study of more than 10,000 men, scientists at Brigham and Women’s Hospital and Harvard Medical School, both in Boston, MA, found that hearing loss is tied to an appreciably higher risk of subjective cognitive decline. In addition, the analysis revealed that the size of the risk went up in line with the severity of hearing loss. The risk of subjective cognitive decline was 30 percent higher among men with mild hearing loss, compared with those with no hearing loss. For men with moderate or severe hearing loss, the risk of subjective cognitive decline was between 42 and 54 percent higher. Subjective cognitive decline refers to changes in memory and thinking that people notice in themselves. Such changes can be an early indication of cognitive decline that objective performance tests do not pick up on. “Our findings,” says lead study author Dr. Sharon Curhan, who works as a physician and epidemiologist, “show that hearing loss […]
A protein that plays a key role in early neural development is also essential for learning and memory in the adult brain. A protein called netrin may boost learning and memory by strengthening neural connections in the adult brain. The protein, called netrin, strengthens connections between brain cells. This is according to recent research led by the Montreal Neurological Institute and Hospital (The Neuro), a teaching and research institute of McGill University in Canada. Scientists already knew that netrin is essential for the development of the embryonic and infant brain, where it helps make connections between brain cells, or neurons. The recent research reveals that the protein also strengthens those neural connections, or synapses, in the adult brain’s hippocampus, an area that is involved in memory and learning. The journal Cell Reports recently published a paper on the study, which the team conducted on cells from developing and adult rat brains. “It was a mystery,” comments senior study author Dr. Timothy E. Kennedy, who runs a research laboratory at The Neuro, “why neurons would continue making netrin in the adult brain after all the connections had already been made in infancy.” Molecule key for synapse strengthening According to Dr. Kennedy, […]
According to a team of Swedish-based researchers, breathing through the nose may help memory storage and consolidation. These findings are published in The Journal of Neuroscience. The way we breathe affects our memory in mysterious ways. Recently, neuroscientists have been scrutinizing the link between smell and memory. Some have suggested that a damaged sense of smell can predict dementia, and others have zoomed in on why that may be. Along the way to unraveling the Proustian mysteries of smells and memory, scientists have picked up several clues. The amygdala, which is a small brain region that processes sensory information, is close to the memory-storing hippocampus. Also, newer research shows that people with a good spatial memory may be better at identifying smells. Information related to time and space is present in the anterior olfactory nucleus, studies have shown. This is a brain area that is involved in the development of Alzheimer’s. New research now adds breathing into the mix. A study carried out by scientists at the Karolinska Institutet in Stockholm, Sweden, finds that breathing through the nose, rather than the mouth, improves olfactory memory. Artin Arshamian, a researcher at the Department of Clinical Neuroscience with the Karolinska Institutet, is […]
(HealthDay News) — Mild memory issues are common from time to time, especially as you age, the U.S. Food and Drug Administration says. Latest Alzheimer’s News The agency says anything that affects the processes of thinking and learning can affect memory. It mentions these common causes of memory loss: Certain drugs can interfere with memory, including over-the-counter and prescription sleeping pills, antihistamines, anti-anxiety medications, antidepressants, schizophrenia medications and pain medicines. Heavy alcohol use can cause a deficiency in vitamin B1, which can affect memory. Stress, particularly because of emotional trauma, can trigger memory loss. Depression may trigger a lack of attention and focus that can affect memory. A blow to the head can trigger memory loss. People with HIV, tuberculosis, syphilis, herpes and other infections affecting the brain may have memory problems. An underactive or overactive thyroid can impact memory. Lack of quality sleep can affect memory. Deficiencies of vitamins B1 or B12 can affect memory. Copyright © 2018 HealthDay. All rights reserved.
The largest genetic study of Alzheimer’s disease to date finds that a “handful of gene variants” increases some people’s risk of both dementia and cardiovascular disease. The findings imply that, in principle, we may be able to repurpose some cardiovascular drugs to prevent or treat Alzheimer’s. The findings of a new study raise the question: could drugs for cardiovascular problems prevent Alzheimer’s? Alzheimer’s disease already affects a large number of older adults in the United States and worldwide, but the Centers for Disease Control and Prevention (CDC) warn that the burden of the condition will double in the U.S. by 2060. Currently, about 5.7 million Americans are living with the condition, and experts expect this number to reach almost 14 million in the next four decades. As a result, both tracking down the root cause of Alzheimer’s and moving closer to a cure are of critical importance. Researchers know that this neurodegenerative condition has a strong genetic component. For instance, a person with one copy of the APOE4 gene variant is twice as likely to develop Alzheimer’s as someone without it, while having two copies may increase the risk up to 12-fold. The APOE gene encodes a protein called apolipoprotein […]
An article, published in JAMA Network this month, attacks what it refers to as pseudomedicine. In particular, the authors are concerned that individuals with dementia and their families are being targeted. Is fear of dementia being used to sell pseudomedicine? Dementia is becoming increasingly prevalent as the population of the United States ages. Currently, 5.7 million people in the U.S. are living with Alzheimer’s, the most common form of dementia. Worldwide, an estimated 47 million individuals are living with dementia. However, to date, there is no cure, and treatments can only relieve certain symptoms for some people. Added to the millions who already have a dementia diagnosis, there are many millions more who are concerned that they, too, might develop dementia one day. A rise in quackery? All of these millions could, potentially, be vulnerable to anyone who claims to have answers, whether they offer improved treatments, preventative methods, or, indeed, cures. This perfect storm of growing prevalence and concern has, according to a recent article, sparked a steep rise in non-evidence-based treatments for dementia and general brain health. With today’s unparalleled access to information of all types, some individuals are being duped into investing in medical interventions that are […]
For the first time, researchers have identified two clusters of genes that appear to generate the neurological hallmarks of dementia. The discovery provides a new path toward drug discovery. Understanding the genetic mechanisms behind Alzheimer’s moves us ever closer to an effective treatment. Dementia is a growing concern throughout the Western world and beyond. According to the Alzheimer’s Association, around 5.7 million adults in the United States are living with Alzheimer’s, the most common form of dementia. By 2050, that figure is expected to rise to about 14 million. As the average lifespan extends, so does the reach of dementia. Currently, there is no cure for dementia and no way to slow its progress. Although many questions about dementia remain unanswered, our understanding is steadily growing. For instance, we know that a protein called tau plays an important role in a number of dementia types. Tau and dementia In healthy nerve cells, tau helps stabilize microtubules — the scaffolding that helps maintain the structure and rigidity of cells. In dementia, however, tau becomes hyperphosphorylated and clumps together in so-called neurofibrillary tangles. Scientists think that when tau is tangled, it damages nerve cells in at least two ways. Firstly, it can […]
By the time that the symptoms of dementia emerge in Alzheimer’s disease, tissue damage is well underway in the brain. Now, scientists propose that specific psychiatric symptoms – such as depression, anxiety, sleep disruption, and loss of appetite – may serve as markers of very early brain changes in Alzheimer’s. Depression and anxiety may be signs of early-stage Alzheimer’s. Working with the Brazilian Biobank for Aging Studies (BBAS) at the University of São Paulo, investigators at the University of California in San Francisco (UCSF) studied results of postmortem brain tissue tests and compared them with psychiatric symptoms obtained from detailed interviews conducted with people who knew the deceased well, such as relatives and carers. They suggest that their study — a paper on which now features in the Journal of Alzheimer’s Disease — reveals that psychiatric symptoms are not the cause of Alzheimer’s, but more likely early indicators of the disease. Such markers could help doctors to diagnose Alzheimer’s disease much earlier and thus increase opportunities for slowing its progress, they note. Better understanding of Alzheimer’s The authors also propose that the findings could alter our understanding of how the biology of Alzheimer’s leads to psychiatric symptoms in people who […]
A drug that scientists are currently developing to treat stroke survivors might also help stave off Alzheimer’s disease. Researchers are trialing a new treatment that may help people with early-stage Alzheimer’s disease. Alzheimer’s disease is the most common form of dementia. According to the Alzheimer’s Association, 5.7 million people in the United States are living with the condition. Current medications can only relieve some symptoms of the disease, and there is not yet any way to halt its progression. The neurodegeneration that occurs in people with Alzheimer’s results from the buildup of a protein called beta-amyloid in the brain. Beta-amyloid is present in the healthy brain, but incorrectly folded proteins can accumulate to form amyloid plaques. These plaques reduce blood flow to the brain, leading to the breakdown of brain cells. Over the years, researchers have investigated many pharmacological routes to tackle these plaques, but, to date, none have led to the development of effective drugs. Recently, researchers from the University of Southern California (USC) in Los Angeles explored an innovative new compound that the scientific community is already scrutinizing. Introducing 3K3A-APC 3K3A-APC is a modified version of activated C protein, which is a blood-based protein that protects brain cells […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News THURSDAY, Dec. 20, 2018 (HealthDay News) — Walking and other types of moderate exercise may help turn back the clock for older adults who are losing their mental sharpness, a new clinical trial finds. The study focused on older adults who had milder problems with memory and thinking skills. The researchers found that six months of moderate exercise — walking or pedaling a stationary bike — turned some of those issues around. Specifically, exercisers saw improvements in their executive function — the brain’s ability to pay attention, regulate behavior, get organized and achieve goals. And those who also made some healthy diet changes, including eating more fruits and vegetables, showed somewhat bigger gains. The effect was equivalent to shaving about nine years from their brain age, said lead researcher James Blumenthal, a professor at Duke University School of Medicine, in Durham, N.C. In contrast, those same mental abilities kept declining among study participants who received health education only. Experts said the findings support the general concept that a healthy lifestyle can help protect the brain as you age. “And it’s never too late to start,” said Keith Fargo, director of scientific programs and […]
For years, many experts have assumed that spending more time in education protects against dementia. The latest study may overturn this long-held theory. A new study examines the links between education and dementia risk over time. It will have escaped no one’s attention that dementia is on the rise. The most common type of dementia is Alzheimer’s. According to the Alzheimer’s Association, an estimated 5.7 million adults in the United States have Alzheimer’s. Primarily due to our increasing lifespan, dementia incidence is set to keep rising. Currently, there is no cure, and treatments can only reduce certain symptoms. For this reason, it is vital that we understand the relevant risk factors and discover ways to prevent or slow down dementia. Some risk factors are well-known, such as smoking and lack of physical activity. Well-known protective factors include sticking to a healthful diet. Education and cognitive reserve Many experts think that the length of time someone spends in education helps protect against dementia. Although studies have generated conflicting or inconclusive results, many researchers believe that higher levels of educational attainment provide an individual with a certain “cognitive reserve.” Scientists believe that this hypothetical reserve lowers the risk or, at the very […]
Latest Alzheimer’s News MONDAY, Nov. 26, 2018 (HealthDay News) — An experimental Alzheimer’s disease vaccine shows promise in animal tests, and researchers say it could have the potential to reduce dementia cases by half. In mice created to develop Alzheimer’s, the vaccine triggered an immune response that reduced accumulation of two toxic proteins associated with the fatal brain disease. There was a 40 percent reduction in beta-amyloid proteins and up to a 50 percent reduction in tau proteins, with no harmful side effects, according to researchers at the University of Texas. But there’s a catch: While such tests showed positive results in mice, research on animals doesn’t always produce the same effects in humans. More study is needed. Still, the researchers remained optimistic. Reductions in these proteins could someday have significant benefits in people at risk for Alzheimer’s disease, said study senior author Doris Lambracht-Washington, of the UT Southwestern Medical Center Brain Institute in Dallas. “If the onset of the disease could be delayed by even five years, that would be enormous for the patients and their families,” she said in a center news release. “The number of dementia cases could drop by half.” Lead researcher Dr. Roger Rosenberg is […]
Alzheimer’s disease is a form of neurocognitive decline that affects millions across the world. The exact cause is unclear, but new research is uncovering the mechanisms that allow Alzheimer’s to become established in the brain. Which brain cells are the most vulnerable to Alzheimer’s? In Alzheimer’s disease, as in other forms of dementia, a defining feature is the accumulation of certain toxic proteins in the brain. These proteins aggregate into plaques that disrupt the communication between brain cells, thus enhancing cognitive problems and other issues. More often than not, researchers identify the protein beta-amyloid as the main culprit in this disruptive process. However, another protein, called tau, is just as important. In a new study, researchers from a series of academic institutions, including the Ohio State University in Columbus, Columbia University Medical Center in New York, NY, and Cambridge University in the United Kingdom, have found that tau accumulates preferentially around a specific type of brain cell. The investigators also revealed that certain genetic profiles may predispose a person to tau aggregations around those cells. Co-lead author of the study Hongjun (Harry) Fu — now an assistant professor in the Department of Neuroscience at Ohio State University — and colleagues […]
An artificial intelligence tool taught to analyze brain scans can accurately predict Alzheimer’s disease several years before a final diagnosis. Researchers used PET scans to train a deep learning algorithm to predict signs of Alzheimer’s. The team responsible suggests that, after further validation, the tool could greatly assist the early detection of Alzheimer’s, giving treatments time to slow the disease more effectively. The researchers, from the University of California in San Francisco, used positron-emission tomography (PET) images of 1,002 people’s brains to train the deep learning algorithm. They used 90 percent of the images to teach the algorithm how to spot features of Alzheimer’s disease and the remaining 10 percent to verify its performance. They then tested the algorithm on PET images of the brains of another 40 people. From these, the algorithm accurately predicted which individuals would receive a final diagnosis of Alzheimer’s. On average, the diagnosis came more than 6 years after the scans. In a paper on the findings, which the Radiology journal has recently published, the team describes how the algorithm “achieved 82 percent specificity at 100 percent sensitivity, an average of 75.8 months prior to the final diagnosis.” “We were very pleased,” says co-author Dr. […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News THURSDAY, Jan. 31, 2019 (HealthDay News) — People with dementia show a different makeup in the bacteria dwelling in their guts, a preliminary study finds — raising questions about whether the “bugs” play some role in the brain disease. Researchers in Japan found that compared with dementia-free older adults, those with the disease typically had a very different gut “microbiome.” The term refers to the trillions of bacteria and other microbes dwelling in the digestive system. As recent studies have been revealing, those gut bugs do more than aid digestion. They appear to affect a range of bodily functions, from immune defenses to the production of vitamins, anti-inflammatory compounds and even chemicals that relay messages among brain cells. Researchers have also found that the makeup of the gut microbiome is linked to risks for various conditions, such as obesity, asthma and type 1 diabetes. Those studies do not prove that gut bacteria directly contribute to, or protect against, those diseases, however. And neither does the new study, experts stressed. The study found only that a group of dementia patients had different gut microbes from dementia-free adults, said Mary Sano, director of the Alzheimer’s […]
A novel genetic approach that repairs broken connections between brain cells could lead to treatments that restore memory capacity in Alzheimer’s disease. By using epigenetics, it may soon be possible to reverse memory loss in Alzheimer’s disease. The new approach reverses changes to gene expression that tend to occur in the later stages of the disease. Scientists at State University of New York at Buffalo demonstrated how the method was able to reverse Alzheimer’s memory decline in mice. Much genetic research on the causes of Alzheimer’s disease focuses on changes in the DNA of genes. The new study, however, focuses on epigenetics, which concerns mechanisms that can switch genes on and off without disturbing their DNA code. A paper about the work now features in the journal Brain. “In this paper,” says senior study author Zhen Yan, Ph.D., who is a professor in the Department of Physiology and Biophysics, “we have not only identified the epigenetic factors that contribute to the memory loss, we also found ways to temporarily reverse them in an animal model of [Alzheimer’s disease].” Alzheimer’s disease and loss of synapses Alzheimer’s disease is the leading cause of dementia. According to the World Health Organization (WHO), between […]
As we age, we may experience a decline in our mental ability. A recent study has concluded that chronic inflammation in midlife might speed up this decline as we get older. Could influencing inflammation slow cognitive decline? The average age of the population of the United States is gradually increasing, so conditions of old age are moving into the spotlight. Growing older is associated with a progressive decline in average thinking abilities. However, it may only affect some people very mildly, while other individuals can develop significant cognitive deficits. Understanding the risk factors involved is of growing importance. We already know some risk factors; for instance, lower levels of physical activity, smoking, and obesity appear to increase the rate of decline. Recently, some scientists have turned their attention toward the potential role of inflammation. Inflammation and its consequences As a protective mechanism that prevents any damage to tissue, inflammation occurs in response to an infection or injury. However, if this acute inflammation continues for longer periods — which doctors call chronic inflammation — it can cause damage. Scientists have already linked inflammation to a range of health concerns, including cardiovascular disease, cancer, diabetes, and asthma. Could inflammation also have a […]
New evidence suggests that atrial fibrillation, in which the heart has an irregular beat, is linked to an increased risk of dementia. This knowledge, however, also indicates a potential preventive strategy, researchers show. An irregular heartbeat speeds up the rate at which cognitive function deteriorates, but there may be an easy way to address this. In a new study paper published yesterday in the journal Neurology, researchers at the Karolinska Institute and Stockholm University, which are in Sweden, explain that atrial fibrillation (A-fib) is linked with an increased risk of developing dementia. In A-fib, the heart’s atria — or the chambers that receive blood and then send it to the ventricles, which pump it out to the rest of the body — beat irregularly. Because of this, blood can pool inside the heart and form clots, which may later circulate to the brain, leading to a stroke. The new study has found that A-fib also increases the risk of another health problem as people age — namely, dementia. However, this warning also comes with an encouraging solution, the authors explain. “Compromised blood flow caused by atrial fibrillation may affect the brain in a number of ways,” as study co-author Chengxuan […]
By Alan MozesHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Nov. 28, 2018 (HealthDay News) — Fast tests designed to help primary care doctors rapidly spot dementia in their elderly patients often get it wrong, a new British report contends. The finding concerns three widely used quick dementia tests: the “Mini-Mental State Examination” (intended to assess mental orientation and verbal memory); the “Memory Impairment Screen” (which tests verbal memory); and “Animal Naming” (which gives patients one minute to quickly name as many animals as they can). The result: more than one-third of the patients were misclassified — as either having or not having dementia — by at least one of the rapid tests in question. “Dementia can be difficult to accurately detect, particularly in a primary care setting,” said study lead author Janice Ranson. But the rapid tests “are important screening tools to help clinicians decide who is likely to benefit from further testing for dementia,” she acknowledged. “Our results suggest that some of the misclassification is due to test biases, such as a patient’s age, ethnicity or education level,” she added. Ranson is a doctoral researcher in clinical epidemiology at the University of Exeter Medical School in England. She and her […]
A new study in mice reveals that Candida albicans — a fungus largely perceived as harmless — can cause memory problems and brain abnormalities that resemble those characteristic of Alzheimer’s disease. C. albicans is the most common and best-studied cause of fungal infections in humans. Candida albicans is a species of fungus that grows naturally in the human gut, mouth, and vagina. Although the yeast is mostly harmless, it can develop into issues ranging from thrush to more serious infections that reach the blood and other organs. C. albicans is the most common cause of fungal infections in humans, as well as the most extensively studied fungal pathogen that affects people. A new study, which appears in the journal Nature Communications, adds to the existing body of knowledge about C. albicans. The new research shows that the fungus can enter the brain, trigger an inflammatory response, and impair memory in mice. Importantly, the infection leads to the formation of abnormal structures in the brain, and these share similarities with amyloid plaques — a hallmark of Alzheimer’s disease. Dr. David B. Corry, a professor of medicine-immunology, allergy, and rheumatology at the Baylor College of Medicine in Houston, TX, is the corresponding […]
Doctors may find it hard to diagnose Alzheimer’s disease before the obvious symptoms set in, and many of the current tests for it are expensive and complicated. However, researchers recently devised a blood test that could accurately detect this condition. Recent research aimed to develop an accurate blood test to diagnose Alzheimer’s. According to the Alzheimer’s Association, the condition will affect an estimated 5.7 million people in the United States by 2050. Despite this, there are few ways of accurately diagnosing Alzheimer’s disease early on. These include MRI and CT scans, which help doctors rule out other conditions that might cause similar symptoms. Another way of diagnosing Alzheimer’s is by collecting cerebrospinal fluid and looking for biomarkers of the disease. This is the most accurate test for this neurodegenerative condition, but it is costly and invasive. For all these reasons, researchers from Brigham and Women’s Hospital in Boston, MA, have been developing a blood test for Alzheimer’s that aims to be accurate, more cost-effective, and less unpleasant. In the study paper, which appears in the journal Alzheimer’s & Dementia, the researchers explain that the test may be able to detect biomarkers of Alzheimer’s disease before the appearance of obvious symptoms. […]
Previous research suggested that hearing loss and abnormalities in the eye are tied to memory loss and a higher Alzheimer’s risk. New evidence now indicates that addressing hearing and sight problems can slow down cognitive decline. Opting for hearing aids and cataract surgery can make a big difference when it comes to slowing down cognitive decline. Existing studies have pointed out that there is a link between the quality of a person’s hearing and their eye health and their exposure to cognitive decline. For instance, one such study covered on Medical News Today suggested that poor hearing may correlate with a poor memory. Another one proposed that we could detect Alzheimer’s disease by looking for tell-tale abnormalities in a person’s eyes. Now, two new papers — each based on studies conducted by the same scientists from the University of Manchester in the United Kingdom — look at the evidence indicating that treating hearing loss and eyesight problems can slow down the development of cognitive decline. One of the papers, published in the journal PLOS One, shows that people who have had surgery for cataract — which is condition that can lead to vision loss in the absence of a surgical […]
Latest Alzheimer’s News WEDNESDAY, Jan. 30, 2019 (HealthDay News) — The polar vortex that has enveloped much of the United States this week poses a special danger to people with Alzheimer’s disease and other types of dementia. “This type of weather can be hazardous for everyone, but even more so for individuals living with Alzheimer’s disease, who may have difficulty noticing temperature and weather changes or knowing who to call for help,” said Charles Fuschillo Jr., CEO and president of the Alzheimer’s Foundation of America. “A few easy steps can go a long way to help family caregivers keep their loved one with Alzheimer’s disease safe,” he added in a foundation news release. It’s important for family members and caregivers to know the signs of hypothermia. Be alert for shivering, exhaustion, sleepiness, slurred speech, memory loss and clumsy motor skills, the foundation advised. Caution is needed when using electric space heaters. They can pose a fire risk, especially when used with extension cords or if they get knocked over. For Alzheimer’s or dementia patients, use space heaters that automatically turn off when they reach a set temperature or tip over, the foundation said. Don’t use electric blankets to keep people […]
A number of warning/advisory letters have been issued to 17 companies for selling illegal products that claim to prevent, treat or cure Alzheimer’s disease and other serious conditions, the U.S. Food and Drug Administration says. Latest Alzheimer’s News The agency said it posted 12 warning letters and five online advisory letters to U.S. and foreign companies illegally selling more than 58 products, many of which are marketed as dietary supplements. The products — which include tablets, capsules and oils and are often sold on websites and social media — have not been reviewed by the FDA and may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment, according to the FDA The companies have 15 days to respond to the FDA and outline how they intend to correct the violations. Product seizures and/or injunctions are among the actions the FDA could take if the violations are not corrected. “Science and evidence are the cornerstone of the FDA’s review process and are imperative to demonstrating medical benefit, especially when a product is marketed to treat serious and complex diseases like Alzheimer’s,” FDA Commissioner Dr. Scott Gottlieb said in an agency news release. “Alzheimer’s is a […]
It is still unclear exactly what causes Alzheimer’s disease, which is a neurodegenerative condition chiefly characterized by memory loss and other forms of cognitive impairment. However, new research is uncovering more of the factors that contribute to its pathology. According to a new study, a blood protein leaked into the brain contributes to cognitive decline. According to existing guidelines, the main mechanism associated with cognitive problems in the brains of people with Alzheimer’s disease is the formation of beta-amyloid plaques. These are buildups of toxic proteins that disrupt the normal functioning of synapses. Synapses are the connections formed between brain cells that allow information to circulate within and to and from the brain. However, in a new study from the Gladstone Institutes in San Francisco, CA, a team of researchers has identified another mechanism that affects how synapses work, contributing to Alzheimer’s pathology. The researchers began by investigating problems that appear in the blood vessel network in the brain, which is another biological characteristic of this form of dementia. Senior investigator Prof. Katerina Akassoglou and her team have for the first time identified a blood-derived protein that leaks into the brain disrupting cell-to-cell communication. The findings, which appear in the […]
Latest Alzheimer’s News MONDAY, Dec. 17, 2018 (HealthDay News) — Lots of Americans will unwrap a scarf or sweater this holiday season. But a growing number will receive a gift that’s potentially life-changing: an at-home genetic testing kit. Home DNA testing yields clues to ancestry and, potentially, genetic risk for medical conditions. But there are a number of things you need to know before you use one of these kits, the Alzheimer’s Foundation of America says. “Genetic testing kits are a popular gift, but the test results can have implications that last long after the holidays,” Lori Frank said in a foundation news release. She’s on the foundation’s medical, scientific and memory screening advisory board. “As with any health decision, consumers should have the right information before deciding to take a genetic test,” Frank said. Because genetic testing has potentially positive and negative impacts, the foundation offers some tips: Be informed. “Some people find the results upsetting and are concerned about the emotional impact to relatives with similar genetic risk, while others feel empowered to proactively take better care of their own health. It’s important to consider all impacts beforehand,” said Dr. J. Wesson Ashford, chair of the medical, scientific […]
Recent research has found that short daily practice of mind-body therapy may help alleviate some of the signs and symptoms that often precede dementia. Practicing an easy type of meditation daily may relieve some dementia symptoms. The researchers behind the new study assessed a group of older adults experiencing memory difficulties who practiced 12 minutes per day of music listening or simple yoga meditation for 12 weeks. Samples of their blood from before and after the 3 months of therapy revealed changes in levels of certain markers with associations to cell aging and Alzheimer’s disease. These changes also linked directly to improvements in subjective assessments of cognitive function, mood, sleep, and quality of life. Dr. Kim Innes, a professor at West Virginia University School of Public Health in Morgantown, led the study and is first author of the study paper, which features in the Journal of Alzheimer’s Disease. Blood markers as predictors of Alzheimer’s The team chose to measure a number of blood markers that “have emerged as possible predictors of cognitive decline and dementia.” These included telomere length, telomerase activity, and levels of certain beta-amyloid peptides with links to Alzheimer’s disease. Telomeres are “protective caps” that work to prevent […]
A recent article raises important questions about the prevalence of firearms in the aging population of the United States. The authors argue that there is a vital need to discuss the relationship between dementia and guns. A recent article investigates the issue of gun ownership in an aging population. Gun ownership is a controversial topic, and people are sure to continue debating it for many years to come. This debate often focuses on young men and violent crime, but a recent article investigates the other end of the age spectrum. Older adults are more likely to own a gun than younger people. An estimated 27 percent of people over the age of 65 years own at least one gun, while 37 percent live in a home where a firearm is present. A seemingly unrelated but equally hot topic is the rise of dementia. Dementia and firearms As dementia occurs almost exclusively later in life, the longer that people live, the more prevalent it becomes. Currently, around 5.7 million people in the U.S. are living with Alzheimer’s disease. Although Alzheimer’s is the most common form of dementia, it only accounts for 60–80 percent of all dementia cases. A recent article in […]
Two new studies now suggest that a noninvasive eye scan could soon be used to catch Alzheimer’s disease early. A simple eye scan may soon detect Alzheimer’s in a matter of seconds. The world’s population is aging rapidly and the prevalence of Alzheimer’s disease is on the rise. For this reason, the need for efficient dementia screening methods that can be applied to millions of people is dire. Current diagnostic practices are either invasive or ineffective. For instance, brain scans are costly, and spinal taps — or lumbar punctures — are invasive and potentially harmful. Specialists currently diagnose Alzheimer’s disease using memory tests and by tracking behavioral changes. However, by the time that the symptoms appear, the disease has already progressed. For these reasons, researchers are hard at work trying to devise newer and better diagnostic tools for Alzheimer’s. For instance, some scientists are trying to use a “sniff test” as a way of assessing whether someone has dementia. Now, researchers at Duke University in Durham, NC, say that Alzheimer’s could be diagnosed in seconds just by looking at a person’s eyes, and scientists at the Sheba Medical Center in Israel concur. Two new studies presented at AAO 2018 — […]
Latest Alzheimer’s News WEDNESDAY, Jan. 9, 2019 (HealthDay News) — Poor sleep is common among Alzheimer’s patients, and researchers say they’re beginning to understand why. Scientists studied 119 people aged 60 and older. Eighty percent had no thinking or memory problems, while the rest had only mild problems. The researchers found that participants with less slow-wave sleep — deep sleep that’s needed to preserve memories and to wake up feeling refreshed — had higher levels of the brain protein tau. Elevated tau levels are a possible sign of Alzheimer’s disease and have been linked to brain damage and mental decline, the scientists said. The findings suggest that poor sleep among older adults could be a warning sign of declining brain health, according to the researchers at Washington University School of Medicine in St. Louis. “We saw this inverse relationship between decreased slow-wave sleep and more tau protein in people who were either cognitively normal or very mildly impaired, meaning that reduced slow-wave activity may be a marker for the transition between normal and impaired,” said first author Dr. Brendan Lucey. He’s an assistant professor of neurology and director of the Washington University Sleep Medicine Center. “Measuring how people sleep may […]
By Maureen SalamonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Dec. 12, 2018 (HealthDay News) — The toll of U.S. military service can be steep for female veterans, with depression, post-traumatic stress disorder and brain injury each significantly raising the odds of later dementia, new research suggests. The study, of more than 100,000 older women veterans, spotlights the risk factors stemming from military service that can lead to thinking and memory problems down the road, said study author Dr. Kristine Yaffe. “It’s really the first time anybody in the world has tried to understand women veterans and their risks for dementia,” said Yaffe, a professor of psychiatry, neurology and epidemiology at the University of California, San Francisco. “Nothing was known about these older women, yet more and more women are going into the military and more younger women are in combat,” she added. Yaffe is also a physician at the San Francisco VA Medical Center. She said her prior research showed similar effects in male veterans. “I thought we should try to understand more about older women veterans and … if some of the things we’ve shown in the past about men also relate to women,” she explained. Women accounted for more […]
(HealthDay News) — If a loved one has symptoms of Alzheimer’s disease, he or she should visit a doctor for a formal evaluation. Latest Alzheimer’s News It may be easier to control the disease if it’s diagnosed early, the Alzheimer’s Association says. Here is the association’s list of other potential benefits of early diagnosis: Better access to treatment options. Possible participation in a clinical trial. More time to improve health concerns, such as obesity and high blood pressure. More time to spend with family and planning for the future. Copyright © 2019 HealthDay. All rights reserved.
What brand names are available for rivastigmine? Exelon, Exelon Patch Is rivastigmine available as a generic drug? GENERIC AVAILABLE: Yes Do I need a prescription for rivastigmine? Yes What are the uses for rivastigmine? What are the side effects of rivastigmine? The most common side effects Exelon and Exelon Patch are: Dizziness Diarrhea Headache Stomach pain Vomiting Nausea Weight loss About one-half of patients who take Exelon and Exelon Patch develop symptoms of nausea, and about one-third vomit at least once, most commonly during the first few weeks of treatment as the dose is slowly increased. Between one in five and one in four patients lose weight during rivastigmine therapy (about 7 to 10 pounds, on average). One in six patients experiences a loss of appetite. About one in fifty patients develops dizziness. Overall, 15% of patients (between one in seven and one in six) discontinue therapy due to side effects. Serious side effects include: What is the dosage for rivastigmine? Exelon and Exelon Patch usually is taken twice daily with meals. Due to gastrointestinal side effects that can be seen early in therapy, rivastigmine therapy is generally started at a low dose. Exelon and Exelon Patch for treating dementia […]
New research suggests that stools from so-called “super donors” have such rich microbial diversity that using them for fecal transplants could cure conditions ranging from inflammatory bowel disease to Alzheimer’s and multiple sclerosis. Scientists have found that stool samples from ‘super donors’ hold the potential for curing a wide range of conditions. Recently, a growing number of studies have discovered diseases that are connected with changes in the gut’s microbiota. Cancer, obesity, depression, and post-traumatic stress disorder are only some of the conditions that researchers have linked with an imbalance in the bacterial composition of our gut. This imbalance bears the name “dysbiosis,” and observational studies have noted a link between microbial dysbiosis and allergies, irritable bowel syndrome, and cardiovascular disease. More recently, Medical News Today reported on research that found connections between gut bacteria and age-related diseases, such as Alzheimer’s or age-induced paralysis. Many of the studies that have illuminated these connections have been conducted in germ-free mice. In these tests, researchers replaced the rodents’ gut microbiotas with healthier bacteria by performing fecal transplants from a healthy donor. Physicians use the same procedure of stool transplantation in human clinical trials. But new research suggests that some stools are better […]
New research, published in the journal Nature Genetics, identifies new genetic risk factors for Alzheimer’s disease. It also uncovers novel biological mechanisms that may lead to this neurodegenerative condition. Scientists have found new genetic locations associated with Alzheimer’s. About 5.7 million people in the United States are currently living with Alzheimer’s disease. A recent report issued by the Centers for Disease Control and Prevention (CDC) predicts that by the year 2060, this number will grow to 13.9 million. Genes play an important role in whether a person will develop Alzheimer’s or not. Researchers estimate that 60–80 percent of the disease is heritable. Therefore, identifying the genes that put some people at risk of Alzheimer’s is an important scientific endeavor. So far, studies have found more than 20 genetic locations that have links with the condition, but these only explain a small percentage of the genetic variance that accounts for Alzheimer’s. So, a team of scientists has set out to uncover more genetic risk factors. Professor Danielle Posthuma, from the Vrije Universiteit University in Amsterdam, Netherlands, together with Dr. Ole Andreassen from the University of Oslo, Norway, and Dr. Stephan Ripke from the Broad Institute in Boston, MA, led the new […]
Latest Alzheimer’s News SUNDAY, Nov. 25, 2018 (HealthDay News) — People caring for a loved one with Alzheimer’s or other types of dementia should focus on four main safety issues, an expert says. Nearly 6 million Americans have Alzheimer’s disease, according to the Alzheimer’s Association. About 16.1 million Americans provide unpaid care for people with Alzheimer’s or other dementias. “When approaching dementia families, I follow the safe and sane rule,” said Dr. Andrew Duxbury, a geriatrician in the Division of Gerontology, Geriatrics and Palliative Care at University of Alabama at Birmingham. “Everything we do needs to make the patient safe and the family sane. In terms of safety, it boils down into the big four: meals, wheels, bills and pills,” he explained in a university news release. In terms of meals, caregivers need to consider whether the person is capable of preparing food, eating healthy and appropriate amounts of food, and has the awareness that they need to eat, Duxbury said. “If any link in that chain breaks, the person may not eat,” he said. When it comes to kitchen safety, the “biggest issue is leaving things on the stove and forgetting to turn the oven off; but if cooking […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Jan. 16, 2019 (HealthDay News) — Staying active in old age may help preserve your memory and thinking skills, a new study suggests. In fact, older people who were physically active kept their minds sharp, even if their brains showed signs of lesions or other markers linked to Alzheimer’s disease or other dementias, researchers found. “Physical activity may provide cognitive reserve” that helps preserve the brain even in the face of dementia, said lead researcher Dr. Aron Buchman. He’s professor of neurology at Rush University Medical Center in Chicago. Lifestyle appears to play a major role in keeping the mind sharp as we age, he said. Other studies have found that keeping socially and mentally active also improves mental skills. “Together, these suggest that a more active lifestyle, including physical, cognitive and social activities, may help maintain cognition in older adults,” Buchman said. Buchman said he doesn’t know how these factors protect the brain, what kind of exercise is best, or how much is protective. Only an association was seen in the study, and more research is needed. “Even if we don’t have treatments for Alzheimer’s disease, there’s a benefit to having […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News TUESDAY, Jan. 29, 2019 (HealthDay News) — Tight control of your blood pressure won’t necessarily spare you from full-blown dementia, a new trial concludes. But it might lower the risk of slight declines in thinking and memory, a condition known as mild cognitive impairment (MCI), the researchers added. The clinical trial is the “first study in history to show that any intervention can reduce your risk of developing mild cognitive impairment, an early form of dementia,” said lead researcher Dr. Jeff Williamson. He is a professor of gerontology and geriatric medicine at Wake Forest School of Medicine, in Winston-Salem, N.C. “What is good for your heart in terms of blood pressure-lowering is also good for your brain,” Williamson added. He noted that the trial ended early, which likely affected the dementia result. “We just didn’t have enough dementia cases develop over time” in the group with less-restricted blood pressure, he explained. High blood pressure affects more than three-fourths of people over the age of 65, and it has been identified as a potential risk factor for MCI and dementia in observational studies, the study authors said in background notes. The new clinical trial […]
In a new study, researchers have found that a bacterium largely responsible for gum disease also contributes to the development of Alzheimer’s disease. A bacterium involved in gum disease boosts Alzheimer’s toxicity. According to data from the National Institute of Dental and Craniofacial Research, 8.52 percent of adults between 20 and 64 years of age in the United States have periodontitis (gum disease). Gum disease is a widespread problem that can lead to more negative outcomes, from tooth loss to an increased risk of cancer. Now, emerging evidence suggests that one of the bacteria involved in periodontitis could also contribute to the accumulation of toxic proteins in the brain, which scientists have associated with the development of Alzheimer’s disease. These findings have emerged from a new study in mice that researchers from Cortexyme, Inc., a pharmaceutical company that aims to develop new therapeutics for Alzheimer’s disease, have conducted. The results of the research — whose lead author is Dr. Stephen Dominy, Cortexyme co-founder — appear in the journal Science Advances. “Infectious agents have been implicated in the development and progression of Alzheimer’s disease before, but the evidence of causation hasn’t been convincing,” notes Dr. Dominy. The bacterium that boosts brain […]
People with a diagnosis of dementia can also face depression. For this reason, they may end up taking antidepressant drugs. Now, a study has found that these drugs may be able to treat not just depression, but dementia itself. A new study tests out the potential of antidepressants to tackle dementia mechanisms in the brain. According to data cited by the Alzheimer’s Association, 1 in 10 people aged 65 and over has Alzheimer’s disease, a form of dementia, characterized chiefly by memory loss, disorientation, and having trouble with normal daily activities. Moreover, people with Alzheimer’s can often also develop mental health issues, especially depression. For this reason, healthcare professionals may prescribe selective serotonin reuptake inhibitors (SSRIs) — a class of antidepressants — to individuals with dementia. Recently, researchers from the University of Waterloo in Ontario, Canada, have found a surprising mechanism at play, namely that SSRIs appear to inhibit the growth of dementia-specific aggregates in the brain. “These are promising findings for people with Alzheimer’s who are on SSRIs,” notes Prof. Praveen Nekkar Rao, one of the current study’s authors. “These finding may not only highlight benefits for people with depression and Alzheimer’s but can also provide insights to serve […]
New research has shown that impaired insulin signaling in the brain, often a feature of diabetes, may negatively impact cognition, mood, and metabolism — all of which are common aspects of Alzheimer’s disease. A new study examines the links between Alzheimer’s and diabetes. Although the conditions are seemingly independent of each other, earlier studies have found that people with type 2 diabetes are more likely to develop Alzheimer’s disease. However, the mechanisms behind this relationship have remained hidden. A recent study investigated the impact of blocking insulin receptors and insulin-like growth factor (IGF1) receptors in mouse models. The work was carried out at the Joslin Diabetes Center, affiliated with Harvard Medical School in Boston, MA. The results reveal that interrupting these similar pathways impaired both learning and memory. The researchers published their findings in the Proceedings of the National Academy of Sciences. Insulin receptors and learning The researchers worked with both the hippocampus and the central amygdala, areas of the brain that help with cognition function, as well as metabolic control. They looked into how mice with disabled insulin and IGF1 receptors tackled mazes, and the results were revealing. First, the researchers allowed the mice to explore the maze to […]
As interest in gut bacteria peaks, they are implicated in yet another condition. Researchers recently identified stark differences in levels of specific gut bacteria in people with dementia. A new study links changes in gut bacteria to dementia. Our bodies swarm with microscopic visitors. On our skin, in our mouths, deep in our lungs, and, of course, nestled in our digestive systems. The bacteria in the gut have long been known to assist the digestive process, but in recent years, it has become clear that they are involved in much, much more. With bacteria now implicated in conditions as diverse as diabetes and schizophrenia, we truly are in the age of the microbiome. Recently, researchers in Japan investigated whether gut bacteria might, one day, help in the diagnosis and even treatment of dementia. Dr. Naoki Saji, from the Center for Comprehensive Care and Research on Memory Disorders at the National Center for Geriatrics and Gerontology in Obu, Japan, led the team of scientists. The researchers will present their findings at the American Stroke Association’s International Stroke Conference 2019 in Honolulu, HI. Examining feces The researchers recruited 128 participants from their memory clinic. The average age was 74.2, and 59 percent […]
Dementia refers to a series of neurodegenerative diseases, such as Alzheimer’s, where a person’s memory and other cognitive abilities decline. A recent study may have found a new risk factor that might predispose people to dementia: lung disease. To limit the risk of dementia, people may also want to look after the health of their lungs, a new study suggests. According to the study by researchers from the University of Minnesota’s School of Public Health in Minneapolis in collaboration with colleagues from other academic institutions in the United States, people who experience lung disease in midlife may have an increased risk of dementia later on. The study’s findings appear in the American Journal of Respiratory and Critical Care Medicine, a journal of the American Thoracic Society. The research indicates associations between both restrictive and obstructive lung diseases and dementia or cognitive impairment risk. Doctors use the term restrictive lung diseases when the lungs are unable to expand. Such diseases include idiopathic pulmonary fibrosis, in which the lungs present scarring, and sarcoidosis, where some lung tissue becomes abnormally swollen. In obstructive lung diseases, something obstructs the air flow in or out of the lungs. The most common type of obstructive lung […]
Gum disease bacteria may play a role in Alzheimer’s disease, researchers say. Latest Alzheimer’s News They studied dead and living patients with diagnosed and suspected Alzheimer’s and found bacteria associated with chronic gum disease in the brains of people with Alzheimer’s, BBC News reported. Tests on mice confirmed the bacteria, Porphyromonas gingivalis could migrate from the mouth to the brain and that a toxic protein they secrete (gingipain) destroyed brain neurons. The bacteria also boosted production of amyloid beta, a component of brain plaques associated with Alzheimer’s, BBC News reported. Further tests on mice showed that drugs that block the toxic proteins produced by the bacteria stopped brain degeneration. The study was published in the journal Science Advances. The researchers said their findings could point to new ways to help people with Alzheimer’s. Currently there is no cure or effective treatment, BBC News reported. The team developed a new drug and plan to test it later this year in a clinical trial with patients who have mild to moderate Alzheimer’s. The study adds to evidence of a link between gum disease and dementia, but it’s still not clear if gum disease bacteria actually trigger Alzheimer’s, said scientists not involved in […]
A new study finds that people with Alzheimer’s disease who also took antidiabetes medication exhibited fewer molecular markers of the neurological condition. These findings could inform future Alzheimer’s treatments. A study examined the molecular pathways of brain tissue and the cells that line the inside of blood vessels in the brains of people with Alzheimer’s and diabetes. New research — led by Vahram Haroutunian, Ph.D., a professor of psychiatry and neuroscience at the Icahn School of Medicine at Mount Sinai in New York City, NY — analyzed the brain tissues of people who had both Alzheimer’s disease and diabetes. The findings suggest that antidiabetes drugs may protect the brain against Alzheimer’s. As Prof. Haroutunian and colleagues explain in their paper, a mounting body of evidence has been pointing to a link between the risk of mild cognitive impairment, dementia, and type 2 diabetes. Additional studies have uncovered an association between an insulin receptor pathway in the brain and the accumulation of Alzheimer’s-specific brain pathologies. Previous studies conducted by the same Prof. Haroutunian and colleagues found that the brains of people with Alzheimer’s who had also undergone treatment for diabetes, such as insulin or antidiabetes medicine, had reduced brain pathologies. So, […]
Dementia and Alzheimer’s disease are similar but not the same. Dementia is a general term and has many different types, of which Alzheimer’s is one. There is sometimes confusion between the two because people often use the terms interchangeably. Dementia is an umbrella term used to describe a set of symptoms that broadly affect cognitive functioning, including: memory thinking and focus problem solving language visual perception Alzheimer’s disease is a specific type of dementia that causes a gradual decline in memory and thinking. What is dementia? Some dementia symptoms can be mild and difficult to detect. Dementia is a syndrome, which means that it describes a collection of symptoms with no specific cause. A syndrome is different from a disease, which has specific symptoms and a common cause. Dementia can affect a wide range of mental functions. As a result, many different diseases and conditions are types of dementia. Alzheimer’s disease is the most common form of dementia, but there are several other types, including: vascular dementia, which results from strokes or other conditions that block blood flow to the brain Lewy body dementia, which is a result of abnormal protein deposits in the brain frontotemporal disorders, which are types […]
(HealthDay News) — It’s taking you longer than it once did to learn a new task. Or you’ve forgotten about today’s doctor’s appointment. Should you be worried? Latest Alzheimer’s News In other words, do you have mild forgetfulness or symptoms of a more serious memory problem? The National Institute on Aging says you should speak to your doctor, who can help determine if your memory and thinking problems are normal or not, and what might be causing them. Signs of a more serious memory issue include: Asking the same questions repeatedly. Getting lost in familiar places. Not being able to follow instructions. Becoming confused about time, people or places. Copyright © 2018 HealthDay. All rights reserved.
Recent research suggests that a maternal diet that is high in an essential nutrient can reduce the impact of Alzheimer’s disease on future generations. Meat, fish, eggs, and dairy are the main dietary sources of choline. In the study, scientists bred mice that were genetically predisposed to develop hallmarks of Alzheimer’s disease from females whose diet contained added choline. The descendants of these females developed fewer disease-associated brain changes and had improved memory skills compared with those of non-supplemented mice. The researchers, who are from Arizona State University (ASU) in Tempe and the Translational Genomics Research Institute in Phoenix, AZ, bred two generations of mice from the choline-supplemented females. They found that the protective effect of “maternal choline supplementation” persisted across multiple generations, even though the descendants’ diets were not enriched with choline. The journal Molecular Psychiatry has now published a paper on the study. Choline: An essential nutrient Choline is an essential nutrient that the body needs for many functions, including early brain development and the preservation of cell structure. While the human body can make some of the choline that it needs, it has to obtain the rest from dietary sources. In the United States, animal products such […]
Men who follow a healthful diet could be protecting their brains, according to a new study that tracked a large group of men for more than 2 decades. Leafy greens and red and orange vegetables correlated with reduced memory loss in a new study. Researchers from the Harvard T.H. Chan School of Public Health in Boston, MA, analyzed data from a study that had followed 27,842 men for 26 years. The men had all filled in detailed surveys about their food and drink intake at the start of the study in 1986 — when they were aged 51 years, on average — and then every 4 years until 2002. The follow-up lasted until 2012, by which time their average age was in the mid- to late-70s. During the last few years of the follow-up, they had also completed short tests to find out whether they had noticed any decline in their own ability to think and remember things. The analysis showed that consuming higher amounts of certain foods and drinks was tied to lower risk of decline in memory and thinking skills. The foods that most strongly showed this effect were leafy greens, red and dark orange vegetables, berry fruits, […]
Type 2 diabetes is a chronic condition that affects the body’s insulin production and blood sugar levels. New research, however, suggests that the scope of this condition may be broader than previously thought, as scientists find a link between type 2 diabetes and cognitive decline over 5 years. New research suggests that type 2 diabetes may affect brain size in midlife. Michele Callisaya, from the University of Tasmania in Hobart, Australia, led the new research. Callisaya and her colleagues set out to investigate if there was an association between type 2 diabetes, on the one hand, and brain atrophy and cognitive decline, on the other. Moreover, in case the researchers found such a connection, they wanted to discover whether there was a causal relationship underlying it. The researchers recruited 705 people aged between 55 and 90 years from the so-called Cognition and Diabetes in Older Tasmanians study and took measures of the participants’ brains and cognition. To the authors’ knowledge, this is the first study to compare both cognition and brain size among people with and without type 2 diabetes. The results appear in Diabetologia, the journal of the European Association for the Study of Diabetes. Type 2 diabetes tied […]
Building on decades of research, a new paper brings us one step closer to a vaccine that targets the neurological hallmarks of Alzheimer’s disease. Prevention may soon be possible. Scientists inch closer to finding a way to prevent Alzheimer’s disease. Alzheimer’s disease, the most common form of dementia, is a degenerative neurological disease. Memory issues are often the first sign of the condition, which steadily progresses over time. Alzheimer’s disease is a growing concern as it appears almost exclusively in older adults. As the number of older people rises in the United States, the number of cases will also increase. Although scientists are still investigating the exact causes of Alzheimer’s disease, they believe that certain neurological markers play a significant role. The disease seems to involve a buildup of specific proteins in the brain called beta-amyloid and tau. Doctors refer to these abnormal congregations as plaques and neurofibrillary tangles respectively. The hunt for a vaccine Current treatments for Alzheimer’s do not stop disease progression, so the search for effective alternatives is ongoing. Some researchers hope that targeting amyloid buildup might make it possible to stop Alzheimer’s in its tracks. Many scientists are on the hunt for a vaccine, including Dr. […]
A recent study in older people suggests that reducing blood pressure to levels below the usual standard can lessen the risk of mild cognitive impairment, which is a condition that often precedes dementia. Lowering blood pressure in seniors could prevent mild cognitive impairment, new research concludes. Scientists at the Wake Forest School of Medicine in Winston-Salem, NC, led a randomized clinical trial involving just under 9,400 adults in their 50s or older with high blood pressure. The objective of the trial, as the investigative team notes in the JAMA study paper, was to “evaluate the effect of intensive blood pressure control on risk of dementia.” The older adults received either intensive blood pressure control or standard treatment. The purpose of intensive control was to bring systolic blood pressure below 120 millimeters of mercury (mm Hg), while that of standard treatment was to lower it to under 140 mm Hg. Systolic blood pressure is the pressure in the arteries when the heart contracts. It is usually the first number in a blood pressure measurement, as in “140 mm Hg over 80 mm Hg,” for instance. The results revealed that significantly fewer of those who received intensive blood pressure control went on […]
Recent research suggests that doing even low-intensity physical activity allows older people to reduce their risk of dementia. Carrying out even basic activities in older age might help maintain brain health. Several factors can affect a person’s chance of developing dementia. Some of the factors, such as age and genetics, are unavoidable. Others, such as smoking and other unhealthful behaviors, are lifestyle choices that a person can change. Regularly exercising and eating a healthful diet may prevent the onset of symptoms, say the Alzheimer’s Association. However, a new study that appears in the journal Neurology has revealed that any kind of physical activity — including basic tasks such as doing housework — may protect a person’s brain when they have already reached old age. The researchers — from Rush University Medical Center in Chicago, IL — studied 454 older adults. Of these, 191 had a diagnosis of dementia. Every participant agreed to donate their brain for medical research purposes when they died. Every year for 2 decades, each person underwent a full physical examination, along with a test, to determine their thinking and memory skills. The scientists gave all the volunteers an activity-monitoring device called an accelerometer around 2 years […]
Ketogenic, or keto, diets are low-carb and fat-rich, and many people who follow such regimens do it to shed excess weight. However, a keto diet may bring other benefits, too. In particular, it may help keep the brain healthy and young, as new research in mice seems to suggest. Can a keto diet protect brain health, and if so, how? A keto diet is high in fat, low in carbohydrates, and has an adequate amount of protein. This kind of diet is meant to trigger ketosis, which is a metabolic process through which the body breaks down fat and protein and transforms them into energy, leading to weight loss. Besides triggering weight loss, a keto diet may also bring other health benefits, as studies have recently suggested. For instance, one such study argued that keto diets could help reduce the side effects of certain cancer therapies. Now, researchers from the Sanders-Brown Center on Aging at the University of Kentucky in Lexington, KY, are assessing evidence suggesting that keto diets may also help stave off cognitive decline. The scientists conducted two studies, both in mice. The findings indicate that keto-type diets can protect neurovascular function, as well as metabolic function, in […]
Exercise is a vital element of a healthful lifestyle; it helps maintain heart health, improve mood, and fight weight gain. New research also suggests that it can protect a person’s cognitive skills, and a new study uncovers fresh information as to how this can happen. How does exercise help protect memory? According to a study covered on Medical News Today last year, engaging in regular, leisurely exercise can help keep the body young and healthy. The same appears to be true for the relationship between exercise and the mind; only 10 minutes of physical activity may boost cognitive function in the short-term. Meanwhile, exercising regularly for 6 months could actually reverse the symptoms of mild cognitive impairment. Starting from such evidence, which suggests that exercise has a protective and even healing effect on brain functioning, a team of researchers from numerous international academic institutions has recently investigated some of the biological mechanisms that underlie this relationship. The researchers came from institutions including the Federal University of Rio de Janeiro in Brazil and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain at Columbia University in New York City, NY. They conducted the new research — the findings […]
Blocking an enzyme could put a stop to the buildup of toxic protein clumps that occurs in the brains of people with Parkinson’s disease. New research reveals that blocking a certain protein clears Lewy bodies — toxic structures that are a hallmark of Parkinson’s disease. This was the conclusion that scientists at Georgetown University Medical Center (GUMC) in Washington, D.C. reached after studying the enzyme, called USP13, in the brains of mice and humans. The study, which features in the journal Human Molecular Genetics, may be the first to explain USP13’s role in the toxic accumulation of protein clumps in the brain. The protein accumulations are called Lewy bodies, and they also occur in other neurodegenerative diseases, including Lewy body dementia and multiple system atrophy. “This study,” says lead author Xiaoguang Liu, an assistant professor of neurology at GUMC, “provides novel evidence that USP13 affects development and clearance of Lewy body protein clumps, suggesting that targeting USP13 may be a therapeutic target in Parkinson’s disease and other similar forms of neurodegeneration.” Parkinson’s disease and Lewy bodies Parkinson’s disease is a degenerative disorder that chiefly affects movement control. Typical symptoms include tremors, stiffness, and bradykinesia, which is a slowness of movement. […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News MONDAY, Dec. 10, 2018 (HealthDay News) — Those Sunday crossword puzzles may not prevent the aging brain from slowing down — but they might protect it in a different way, a new study suggests. Researchers looked at the “use it or lose it” theory on brain health. The concept holds that mentally engaging activities — from reading to crosswords to board games — may help the brain resist dementia later in life. In this study, older adults who said they enjoyed those pastimes were no less likely to show signs of mental decline over time, versus other older folks. But they did, on average, score higher on standard tests of mental sharpness. That means that while they did decline over time, they did so from a higher “starting point,” the researchers explained. “The results indicate that a lifetime of engagement lifts you to a high point from which you decline, and that can be considered as passive cognitive reserve,” said lead researcher Roger Staff, of the University of Aberdeen in Scotland. “Starting from a high point,” he said, “will mean that the threshold at which you are considered impaired will be farther into […]
New research finds that an HIV enzyme plays a crucial role in driving Alzheimer’s-related brain pathology by altering the APP gene. The findings warrant “immediate clinical evaluation of HIV antiretroviral therapies in people with Alzheimer’s disease,” say the authors of the study. The revelations of a recent study suggest that HIV drugs might successfully treat Alzheimer’s disease. Deemed “the most under-recognized public health crisis of the 21st century,” Alzheimer’s disease is the 6th leading cause of death in the United States and has no known cure. Currently, 5.7 million people ln the U.S. are living with the condition, and the Centers for Disease Control and Prevention (CDC) predict that the burden of the disease will double by 2060. Alzheimer’s also puts a significant strain on the American healthcare system. According to recent estimates, Alzheimer’s and other forms of dementia cost the U.S. $226 billion in 2015, and loved ones spend billions of unpaid hours caring for people with the condition. About 40 percent of these caregivers develop depression. The medical community is hard at work trying to understand how this debilitating disorder occurs and what can be done to stop it. For instance, one of the clues that researchers have […]
close
The information contained within this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Members contribute personal experiences by sharing what did or didn’t work to address their concern and help educate others which may expedite recovery. As such, always seek the advice of your physician or other qualified health provider with any questions about your medical condition. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
Recent Comments